Telomir Pharmaceuticals Financial Ratios for Analysis 2022-2024 | TELO

Fifteen years of historical annual and quarterly financial ratios and margins for Telomir Pharmaceuticals (TELO).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
0.330.05
--
0.03-
--
--
--
--
--
--
--
--
--
--
-380.1991.13
-380.1991.13
-273.83-1,752.82
-380.1991.13
0.12-0.03
-0.13-0.02
-0.13-0.02

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-31
3.937.20----
------
------
------
------
------
------
------
------
------
------
------
------
-92.44-207.34----
-92.44-207.34----
-68.94-178.54----
-92.44-207.34----
0.050.10----
-0.12-0.070.00-0.03-0.030.00
-0.12-0.07--0.03-0.03-